The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
The SYK tyrosine kinase: a crucial player in diverse biological functions
Open accessAbstract
Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling. However, recent reports indicate that SYK also mediates other, unexpectedly diverse biological functions, including cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation and vascular development. SYK is activated by C-type lectins and integrins, and activates new targets, including the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome. Studies using Drosophila melanogaster suggest that there is an evolutionarily ancient origin of SYK-mediated signalling. Moreover, SYK has a crucial role in autoimmune diseases and haematological malignancies. This Review summarizes our current understanding of the diverse functions of SYK and how this is being translated for therapeutic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SYK is perhaps best known for the critical role that it plays in mounting protective antifungal immune responses downstream of C-type lectin (CLEC) receptors expressed on innate immune cells (Lionakis et al., 2017; Mocsai et al., 2010).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Mocsai et al., 2010
In the citing paper
“However, recent studies indicate that it is also involved in innate immunity and non-immune functions.”
From The Role of Reactive Species on Innate Immunity (2022) · cites this paper as [96]
In the citing paper
“Upon ITAM phosphorylation, the SYK tyrosine kinase is recruited to the receptor and its activation leads to downstream phosphorylation events including activation of SHP-1 and RAC (11, 12)”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,651
Signalling through C-type lectin receptors: shaping immune responses
Geijtenbeek, T. B. H., & Gringhuis, S. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2569 · Cited by 1,449
Reth, M. G. (1989) · Nature · doi:10.1038/338383b0 · Cited by 1,430
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Self-citationDectin-1: a signalling non-TLR pattern-recognition receptor
Brown, G. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1745 · Cited by 1,158
Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence
Groß, O., Poeck, H., Bscheider, M., Dostert, C., Hannesschläger, N., Endres, S., Hartmann, G., Tardivel, A., Schweighoffer, E., Tybulewicz, V. L. J., et al. (2009) · Nature · doi:10.1038/nature07965 · Cited by 947
Self-citationRogers, N. C., Slack, E. M. C., Edwards, A. D., Nolte, M. A., Schulz, O., Schweighoffer, E., Williams, D. L., Gordon, S., Tybulewicz, V. L. J., Brown, G. D., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.004 · Cited by 897
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,003
Mu, L., Tu, Z., Miao, L., Ruan, H., Kang, N., Hei, Y., Chen, J., Wei, W., Gong, F., Wang, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06744-7 · Cited by 48
Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure
Tsounis, E. P., Tourkochristou, E., Mouzaki, Α., & Triantos, C. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i21.2727 · Cited by 46
Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases
Tang, S., Yu, Q., & Ding, C. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2040014 · Cited by 46
Macrophages in aseptic loosening: Characteristics, functions, and mechanisms
Cong, Y., Wang, Y., Yuan, T., Zhang, Z., Ge, J., Meng, Q., Li, Z., & Sun, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122057 · Cited by 46
Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia.
Wiestner, A. U. (2012) · PubMed · doi:10.1182/asheducation-2012.1.88 · Cited by 45
Patel, D., Gaikwad, S., Challagundla, N., Nivsarkar, M., & Agrawal-Rajput, R. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.11.026 · Cited by 45
Dautova, Y., Kapustin, A. N., Pappert, K., Epple, M., Okkenhaug, H., Cook, S. J., Shanahan, C. M., Bootman, M. D., & Proudfoot, D. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.12.007 · Cited by 47
Issara-Amphorn, J., Chancharoenthana, W., Visitchanakun, P., & Leelahavanichkul, A. (2020) · Journal of Innate Immunity · doi:10.1159/000509111 · Cited by 45
Baker, M. C., Chaichian, Y., Genovese, M. C., Derebail, V. K., Rao, P. S., Chatham, W. W., Bubb, M., Lim, S. S., Hajian, H., Gurtovaya, O., et al. (2020) · RMD Open · doi:10.1136/rmdopen-2020-001490 · Cited by 45
Spertini, C., Baïsse, B., & Spertini, O. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.318022 · Cited by 46
Heme controls the regulation of protein tyrosine kinases Jak2 and Src
Xiao, Y., Balamurugan, P., Arvey, A. J., Leslie, C. S., & Li, Z. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.101 · Cited by 44
Chang, N., Li, T. T., Kim, J. J., Landolt-Marticorena, C., Fortin, P. R., Gladman, D. D., Urowitz, M. B., & Wither, J. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.01.009 · Cited by 44
Syk phosphorylation – a gravisensitive step in macrophage signalling
Brungs, S., Kolanus, W., & Hemmersbach, R. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0088-8 · Cited by 45
Novel small molecule therapeutics in rheumatoid arthritis
Kelly, V., & Genovese, M. C. (2013) · Rheumatology · doi:10.1093/rheumatology/kes367 · Cited by 44
Albada, B., Wieberneit, F., Dijkgraaf, I., Harvey, J. H., Whistler, J. L., Stoll, R., Metzler‐Nolte, N., & Fish, R. H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303010k · Cited by 44
Wu, Y., Lan, C., Ren, D., & Chen, G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721258 · Cited by 44
Systematic characterization of basophil anergy
Puan, K. J., Andiappan, A. K., Lee, B. T. K., Kumar, D., Lai, T. S., Yeo, G., Bercin, D., Starke, M., Haase, D., Lum, J., et al. (2016) · Allergy · doi:10.1111/all.12952 · Cited by 44
Challenges to develop novel anti‐inflammatory and analgesic drugs
Botz, B., Bölcskei, K., & Helyes, Z. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1427 · Cited by 44
Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis
Torres-Hernandez, A., Wang, W., Nikiforov, Y. E., Tejada, K., Torres, L. E., Kalabin, A., Wu, Y., Haq, M. I. U., Khan, M. Y., Zhao, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0734-5 · Cited by 45
Hepper, I., Schymeinsky, J., Weckbach, L. T., Jakob, S. M., Frommhold, D., Sixt, M., Laschinger, M., Sperandio, M., & Walzog, B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100878 · Cited by 49
Protein tyrosine kinases in neutrophil activation and recruitment
Zarbock, A., & Ley, K. F. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.02.009 · Cited by 43
Zwolanek, F., Riedelberger, M., Stolz, V., Jenull, S., Istel, F., Köprülü, A. D., Ellmeier, W., & Kuchler, K. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004525 · Cited by 43
Novel therapeutic agents for B-cell lymphoma: developing rational combinations
Reeder, C. B., & Ansell, S. M. (2010) · Blood · doi:10.1182/blood-2010-06-255067 · Cited by 43
HemITAM: A single tyrosine motif that packs a punch
Bauer, B., & Steinle, A. (2017) · Science Signaling · doi:10.1126/scisignal.aan3676 · Cited by 46
CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond
Sung, P., Chang, W., & Hsieh, S.-L. E. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1580-4_3 · Cited by 43
Biswas, P., Dey, D., Rahman, A., Islam, M. A., Susmi, T. F., Kaium, M. A., Hasan, M. N., Rahman, M. H., Mahmud, S., Saleh, M. A., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090888 · Cited by 43
Ding, Q., Liu, H., Yan, L., Chen, L., Chen, Y., Kim, J. S., & Mei, L. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505911 · Cited by 42
Stevens, M. G. H., Peelman, L. J., Spiegeleer, B. M. J. D., Pezeshki, A., de Walle, G. R. V., Duchateau, L., & Burvenich, C. (2011) · Journal of Dairy Science · doi:10.3168/jds.2010-3563 · Cited by 44
Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection
Campuzano, A., Castro-Lopez, N., Wozniak, K. L., Wager, C. M. L., & Wormley, F. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169347 · Cited by 42
Joshi, S., Liu, K. X., Zulcic, M., Singh, A. R., Skola, D., Glass, C. K., Sanders, P. D., Sharabi, A. B., Pham, T. V., Tamayo, P., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0947 · Cited by 43
Engineering synthetic phosphorylation signaling networks in human cells
Yang, X., Rocks, J. W., Jiang, K., Walters, A. J., Rai, K., Liu, J., Nguyen, J., Olson, S. D., Mehta, P., Collins, J. J., et al. (2025) · Science · doi:10.1126/science.adm8485 · Cited by 41
Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors
Neuhaus, B., Bühren, S., Böck, B. C., Alves, F., Vogel, W. F., & Kiefer, F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0676-8 · Cited by 41
Targeting the B-cell receptor signaling pathway in B lymphoid malignancies
Buchner, M., & Müschen, M. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000048 · Cited by 42
Luz, S., Kongsuphol, P., Mendes, A. I., Romeiras, F. M., Sousa, M., Schreiber, R., Matos, P., Jordan, P., Mehta, A., Amaral, M. D., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05517-11 · Cited by 41
Mendes, A. I., Matos, P., Moniz, S., Luz, S., Amaral, M. D., Farinha, C. M., & Jordan, P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05152-11 · Cited by 41
Pyrrolopyrazines as Selective Spleen Tyrosine Kinase Inhibitors
Padilla, F., Bhagirath, N., Chen, S., Chiao, E. T., GOLDSTEIN, D. M., Hermann, J. C., Hsu, J., Kennedy‐Smith, J. J., Kuglstatter, A., Liao, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301720p · Cited by 41
Németh, T., Virtic, O., Sitaru, C., & Mócsai, A. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.05.017 · Cited by 41
Self-citationLupus nephritis and B-cell targeting therapy
Cassia, M. A., Alberici, F., Gallieni, M. A., & Jayne, D. R. W. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1366855 · Cited by 41
New roles for B cell receptor associated kinases: when the B cell is not the target
Nguyen, P., Niesen, E., & Hallek, M. J. (2019) · Leukemia · doi:10.1038/s41375-018-0366-8 · Cited by 41
Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells
Müller, G., Lübow, C., & Weindl, G. (2019) · Autophagy · doi:10.1080/15548627.2019.1686728 · Cited by 41
Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia
Cremer, A., Ellegast, J. M., Alexe, G., Frank, E. S., Ross, L. S., Chu, S. H., Pikman, Y., Robichaud, A. L., Goodale, A. B., Häupl, B., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0209 · Cited by 42
Diverse innate stimuli activate basophils through pathways involving Syk and IκB kinases
Pellefigues, C., Mehta, P. H., Chappell, S., Yumnam, B., Old, S. I., Camberis, M., & Gros, G. S. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019524118 · Cited by 41
Mageau, A., Terriou, L., Ebbo, M., Souchaud-Debouverie, O., Orvain, C., Graveleau, J., Lega, J., Ruivard, M., Viallard, J., Chèze, S., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26378 · Cited by 41
Mazzi, P., Caveggion, E., Lapinet, J. A., Lowell, C. A., & Berton, G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402011 · Cited by 41
Applications of oxetanes in drug discovery and medicinal chemistry
Huang, G., Hucek, D. G., Cierpicki, T., & Grembecka, J. E. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115802 · Cited by 40
BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma
Wiestner, A. U. (2014) · Hematology · doi:10.1182/asheducation-2014.1.125 · Cited by 41
Mechanisms of tissue damage in arthritis
Blüml, S., Redlich, K., & Smolen, J. S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0442-8 · Cited by 41
Buchner, M., Swaminathan, S., Chen, Z., & Müschen, M. (2014) · Immunological Reviews · doi:10.1111/imr.12235 · Cited by 41
Regulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity
Farinha, C. M., Swiatecka‐Urban, A., Brautigan, D. L., & Jordan, P. (2016) · Frontiers in Chemistry · doi:10.3389/fchem.2016.00001 · Cited by 40
Syk and Src-targeted anti-inflammatory activity of aripiprazole, an atypical antipsychotic
Yoo, S., Kim, M., & Cho, J. Y. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.006 · Cited by 40
Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia
Bartaula-Brevik, S., Brattås, M. K., Tvedt, T. H. A., Reikvam, H., & Bruserud, Ø. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1459562 · Cited by 40
Chen, Y., Tibbs‐Cortes, L. E., Ashley, C., Putz, A. M., Lim, K., Dyck, M. K., Fortin, F., Plastow, G. S., Dekkers, J. C. M., Harding, J. C. S., et al. (2020) · BMC Genomics · doi:10.1186/s12864-020-06994-0 · Cited by 40
Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function
Zheng, T. J., Lofurno, E. R., Melrose, A. R., Lakshmanan, H. H. S., Pang, J., Phillips, K. G., Fallon, M. E., Kohs, T. C. L., Ngo, A. T. P., Shatzel, J. J., et al. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2020 · Cited by 42
TRIM31 facilitates K27-linked polyubiquitination of SYK to regulate antifungal immunity
Wang, X., Zhang, H., Shao, Z., Zhuang, W., Sui, C., Liu, F., Chen, X., Hou, J., Kong, L., Liu, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00711-3 · Cited by 40
New Approaches to Myelodysplastic Syndrome Treatment
Bazinet, A., & Bravo, G. M. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00965-1 · Cited by 40
The link between rheumatic disorders and inborn errors of immunity
Sogkas, G., & Witte, T. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104501 · Cited by 42
Wang, Y., Sun, J., Zhu, K., Wang, D., Zhao, X., Zhang, H., Wu, S., Wang, J., & Wang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02764-3 · Cited by 41
Moroi, A. J., & Watson, S. P. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12954 · Cited by 39
Perova, T., Grandal, I., Nutter, L. M. J., Papp, E., Matei, I. R., Beyene, J., Kowalski, P. E., Hitzler, J. K., Minden, M. D., Guidos, C. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008661 · Cited by 39
Management of primary Sjögren’s syndrome: recent developments and new classification criteria
Papa, N. D., & Vitali, C. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x17746319 · Cited by 39
Aldawsari, M. F., Alalaiwe, A. S., Khafagy, E., Saqr, A. A., Alshahrani, S. M., Alsulays, B. B., Alshehri, S., Lila, A. S. A., Rizvi, S. M. D., & Hegazy, W. A. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136833 · Cited by 39
Murata, Y., Kotani, T., Supriatna, Y., Kitamura, Y., Imada, S., Kawahara, K., Nishio, M., Daniwijaya, E. W., Sadakata, H., Kusakari, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510167112 · Cited by 39
Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Gómez-Puerta, J. A., & Mócsai, A. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113139990094 · Cited by 39
Self-citationFumagalli, L., Campa, C. C., Germena, G., Lowell, C. A., Hirsch, E., & Berton, G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201951 · Cited by 39
C-Type Lectin Receptors Orchestrate Antifungal Immunity
Wevers, B. A., Geijtenbeek, T. B. H., & Gringhuis, S. I. (2013) · Future Microbiology · doi:10.2217/fmb.13.56 · Cited by 38
Guided Antithrombotic Therapy: Current Status and Future Research Direction
Fuster, V., Bhatt, D. L., Califf, R. M., Michelson, A. D., Sabatine, M. S., Angiolillo, D. J., Bates, E., Cohen, D. J., Coller, B. S., Furie, B., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.105908 · Cited by 38
Tsiantoulas, D., Kiss, M. G., Gritti, B. B., Bergthaler, A., Mallat, Z., Jumaa, H., & Binder, C. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03688-8 · Cited by 37
Samavedam, U. K. S. R. L., Mitschker, N., Kasprick, A., Bieber, K., Schmidt, E., Laskay, T., Recke, A., Goletz, S., Vidarsson, G., Schulze, F. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00249 · Cited by 37
Issara-Amphorn, J., Somboonna, N., Pisitkun, P., Hirankarn, N., & Leelahavanichkul, A. (2020) · Lupus · doi:10.1177/0961203320941106 · Cited by 37
Sharman, J. P., & Paolo, J. A. D. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716636542 · Cited by 38
Frampton, S., Smith, R., Ferson, L., Gibson, J., Hollox, E. J., Cragg, M. S., & Strefford, J. C. (2024) · Immunological Reviews · doi:10.1111/imr.13401 · Cited by 37
Intraluminal crawling versus interstitial neutrophil migration during inflammation
Pick, R., Brechtefeld, D., & Walzog, B. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.008 · Cited by 36
Hsu, J., Gu, Y., Tan, S., Narula, S. K., DeMartino, J. A., & Liao, C. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.12.007 · Cited by 36
Lin, J., Kurilova, S., Scott, B. L., Bosworth, E., Iverson, B., Bailey, E. M., & Hoppe, A. D. (2016) · BMC Immunology · doi:10.1186/s12865-016-0143-2 · Cited by 36
Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to Candida Species
Negoro, P. E., Xu, S., Dagher, Z., Hopke, A. R., Reedy, J. L., Feldman, M. B., Khan, N. S., Viens, A. L., Alexander, N. J., Atallah, N. J., et al. (2020) · mBio · doi:10.1128/mbio.02043-19 · Cited by 37
Hatton, O., Lambert, S. L., Krams, S., & Martinez, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042610 · Cited by 35
Xue, L., Geahlen, R. L., & Tao, W. A. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o113.027722 · Cited by 36
Intracellular trafficking of bacterial toxins
Williams, J. M., & Tsai, B. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.03.019 · Cited by 36
Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease
Ma, T. K.-W., McAdoo, S. P., & Tam, F. W. K. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000446879 · Cited by 36
Li, X., Lee, Y. J., Jin, F., Park, Y. N., Deng, Y., Kang, Y., Yang, J., Chang, J., Kim, D. Y., Kim, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06835-3 · Cited by 37
Fan, Z., Su, D., Li, Z. C., Sun, S., & Ge, Z. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03313-2 · Cited by 37
Immunopharmacological modulation of mast cells
Borriello, F., Granata, F., Varricchi, G., Genovese, A., Triggiani, M., & Marone, G. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.002 · Cited by 36
Wex, E., Bouyssou, T., Duechs, M. J., Erb, K. J., Gantner, F., Sanderson, M. P., Schnapp, A., Stierstorfer, B., & Wollin, L. (2011) · European Journal of Immunology · doi:10.1002/eji.201141502 · Cited by 35
SYK Allelic Loss and the Role of Syk-Regulated Genes in Breast Cancer Survival
Blancato, J. K., Graves, A., Rashidi, B., Moroni, M., Tchobe, L., Özdemirli, M., Kallakury, B., Makambi, K. H., Marian, C., & Mueller, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087610 · Cited by 35
Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia
Uckun, F. M., Qazi, S., Cely, I., Şahin, K., Shahidzadeh, A., Özercan, İ. H., Yin, Q., Gaynon, P. S., Termuhlen, A. M., Cheng, J., et al. (2013) · Blood · doi:10.1182/blood-2012-11-470633 · Cited by 35
Braegelmann, C., Hölzel, M., Ludbrook, V. J., Dickson, M. C., Turan, N., Ferring‐Schmitt, S., Sternberg, S., Bieber, T. R. M., Kuhn, A., & Wenzel, J. (2016) · Experimental Dermatology · doi:10.1111/exd.12986 · Cited by 35
Penton, P. C., Wang, X., Amatullah, H., Cooper, J. M., Pollitt, K. J. G., North, M. L., Khanna, N., Scott, J. A., & Chow, C. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.039 · Cited by 35
Matera, A., Compagnion, A.-C., Pedicone, C., Kotah, J. M., Ivanov, A., Monsorno, K., Labouèbe, G., Leggio, L., Pereira-Iglesias, M., Beule, D., et al. (2025) · Immunity · doi:10.1016/j.immuni.2024.11.003 · Cited by 34
Inhibition of spleen tyrosine kinase as treatment of postoperative ileus
van Bree, S. H. W., Gomez‐Pinilla, P. J., van de Bovenkamp, F. S., Giovangiulio, M. D., Farro, G., Némethova, A., Cailotto, C., de Jonge, W. J., Lee, K., Ramírez-Molina, C., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302615 · Cited by 34
Till, K. J., Pettitt, A. R., & Slupsky, J. R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402304 · Cited by 34
Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation
Youn, Y.-J., Lee, Y.-B., Kim, S.-H., Jin, H. K., Bae, J., & Hong, C.-W. (2021) · Immune Network · doi:10.4110/in.2021.21.e16 · Cited by 35
B cells and antibodies in refractory immune thrombocytopenia
Roeser, A., Lazarus, A. H., & Mahévas, M. (2023) · British Journal of Haematology · doi:10.1111/bjh.18773 · Cited by 34
TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function
Back, S. H., Adapala, N. S., Barbe, M. F., Carpino, N., Tsygankov, A. Y., & Sanjay, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1203-2 · Cited by 34
Spleen Tyrosine Kinase Regulates AP-1 Dependent Transcriptional Response to Minimally Oxidized LDL
Choi, S., Wiesner, P., Almazan, F., Kim, J., & Miller, Y. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032378 · Cited by 34
Advances in melanoma senescence and potential clinical application
Giuliano, S., Ohanna, M., Ballotti, R., & Bertolotto, C. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00820.x · Cited by 39
Karsdal, M. A., Bay‐Jensen, A., Leeming, D. J., Henriksen, K., & Christiansen, C. (2013) · Biomarkers · doi:10.3109/1354750x.2013.789084 · Cited by 34
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation
Wu, N., Huang, D.-Y., Wang, L., Kannagi, R., Fan, Y.-C., & Lin, W. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.381 · Cited by 33
Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury
Häußler, V., Arumugam, T. V., Magnus, T. U., & Gelderblom, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00875 · Cited by 34
Yu, Y., Rahmanto, Y. S., Lee, M.-H., Wu, P.-H., Phillip, J. M., Huang, C., Vitolo, M. I., Gaillard, S. L., Martin, S. S., Wirtz, D., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0241-0 · Cited by 33
Mohanraj, M., Sekar, P., Liou, H., Chang, S.-F., & Lin, W. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1135-4 · Cited by 33
Metadata
- Authors
- Mócsai, A., Ruland, J., & Tybulewicz, V. L. J.
- Affiliations
- Semmelweis University (HU)
- TUM Klinikum (DE)
- National Institute for Medical Research (GB)
- Corresponding author
- Mócsai, Attila
- Venue
- Nature Reviews Immunology
- Published
- 2010-05-14
- Volume
- 10
- Issue
- 6
- Pages
- 387-402
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4782221
- OpenAlex
- W2017341404
- Cited by
- 1,368
- References
- 194
- Citations by year
- 2026: 71 · 2025: 94 · 2024: 107 · 2023: 111 · 2022: 99 · 2021: 100 · 2020: 78 · 2019: 76 · 2018: 75 · 2017: 87 · 2016: 78 · 2015: 70 · 2014: 87 · 2013: 78 · 2012: 84
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Wellcome Trust (087782)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Syk, innate immune recognition, C-type lectin, integrins, NLRP3 inflammasome, osteoclast maturation, bone metabolism, platelet activation, vascular development, cell adhesion, autoimmune disease, B-cell lymphoma, therapeutic target, Drosophila melanogaster
- MeSH terms
- Syk Kinase, Animals, Cell Adhesion, Humans, Protein-Tyrosine Kinases, Receptors, Immunologic, Signal Transduction, Cell Lineage, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review